2024 New Zealand Infectious Disease Testing Market Shares-Competitive Analysis of Leading and Emerging Market Players
This new report provides infectious diseases testing market shares.
The report analyses current and emerging suppliers of infectious diseases testing analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include:
Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujifilm Wako
Fujirebio
Grifols
Hologic
Illumina
LabCorp
Leica Biosystems/Kreatech
Li-Cor Biosciences
Myriad Genetics
Proteome Sciences
Qiagen
Quest Diagnostics
QuidelOrtho
Roche
Scienion
Shimadzu
Siemens Healthineers
Takara Bio
Tecan Group
Thermo Fisher
The report analyses current and emerging suppliers of infectious diseases testing analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include:
Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujifilm Wako
Fujirebio
Grifols
Hologic
Illumina
LabCorp
Leica Biosystems/Kreatech
Li-Cor Biosciences
Myriad Genetics
Proteome Sciences
Qiagen
Quest Diagnostics
QuidelOrtho
Roche
Scienion
Shimadzu
Siemens Healthineers
Takara Bio
Tecan Group
Thermo Fisher
More Publications
2024 New Zealand Nucleic Acid Testing (NAT) Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 2,850.00
July 2020
1120 pages
2021 New Zealand Tumor Marker Market Assessment-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 3,500.00
March 2021
535 pages
2020-2025 New Zealand Nucleic Acid Testing (NAT) Diagnostics Database: Market Shares and Forecasts for 100 Tests-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 1,850.00
December 2020
-
2021 New Zealand Coagulation Testing Market Assessment-Chromogenic, Immunodiagnostic, Molecular Test Volume and Sales Segment Forecasts-Competitive Shares and Growth Strategies, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 2,500.00
January 2021
350 pages
